Lexicon Pharmaceuticals Inc (LXRX)
0.8634
+0.09
(+11.88%)
USD |
NASDAQ |
Nov 22, 16:00
0.8755
+0.01
(+1.40%)
After-Hours: 20:00
Lexicon Pharmaceuticals Gross Profit Margin (Quarterly): 95.94% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 95.94% |
June 30, 2024 | 89.92% |
March 31, 2024 | 97.26% |
December 31, 2023 | 90.03% |
September 30, 2023 | 95.68% |
June 30, 2023 | 97.48% |
March 31, 2023 | |
December 31, 2022 | |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | |
September 30, 2021 | |
June 30, 2021 | |
March 31, 2021 | |
December 31, 2020 |
Date | Value |
---|---|
September 30, 2020 | 90.46% |
June 30, 2020 | 92.06% |
March 31, 2020 | 92.90% |
December 31, 2019 | 91.13% |
September 30, 2019 | 99.80% |
June 30, 2019 | 86.29% |
March 31, 2019 | 94.00% |
December 31, 2018 | 96.67% |
September 30, 2018 | 92.09% |
June 30, 2018 | 93.93% |
March 31, 2018 | 97.90% |
December 31, 2017 | 98.44% |
September 30, 2017 | 97.78% |
June 30, 2017 | 95.54% |
March 31, 2017 | 98.77% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
89.92%
Minimum
Jun 2024
97.48%
Maximum
Jun 2023
93.28%
Average
92.48%
Median
Gross Profit Margin (Quarterly) Benchmarks
Viatris Inc | 38.90% |
Halozyme Therapeutics Inc | 82.96% |
Perspective Therapeutics Inc | -- |
Quanterix Corp | 58.03% |
Autonomix Medical Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -115.1% |
Return on Assets | -66.89% |
Return on Invested Capital | -75.24% |
Profit Margin (Quarterly) | -3.70K% |
Operating Margin (Quarterly) | -3.64K% |
Return on Net Operating Assets | -400.2% |